Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Zantac TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: ranitidine
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 300mg (as hydrochloride) effervescent tablet strip packWhat this medicine is used for
(ARTG)
1. Short-term treatment of provenduodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ucler. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS MJG" on one side and flat on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 18 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 4 in foil strips sample pack pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 300mg (as hydrochloride) effervescent tablet tubeWhat this medicine is used for
(ARTG)
1. Short-term treatment of provenduodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ucler. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS MJG" on one side and flat on the other.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 15, 30 in polypropylene tubes pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 300mg (as hydrochloride) effervescent tablet tubeWhat this medicine is used for
(ARTG)
1. Short-term treatment of provenduodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ucler. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS MJG" on one side and flat on the other.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 15, 30 in polypropylene tubes pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg (as hydrochloride) effervescent tablet tubeWhat this medicine is used for
(ARTG)
Short term treatment of proven duodenal and gastric ulcer. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. Treatment of gastrinoma (Zollinger-Ellison syndrome). Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. Treatment of scleroderma oesophagitis. NEW INDICATIONS AS AT 2 NOVEMBER 1993: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short- term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and siomple drug therapies such as antacids. 6. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate. INDICATIONS AS AT 31 OCTOBER 1995: Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS LHK" on one side and flat on the other.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 10, 30, 60 in polypropylene tubes pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg (as hydrochloride) effervescent tablet tubeWhat this medicine is used for
(ARTG)
Short term treatment of proven duodenal and gastric ulcer. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. Treatment of gastrinoma (Zollinger-Ellison syndrome). Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. Treatment of scleroderma oesophagitis. NEW INDICATIONS AS AT 2 NOVEMBER 1993: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short- term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and siomple drug therapies such as antacids. 6. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate. INDICATIONS AS AT 31 OCTOBER 1995: Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS LHK" on one side and flat on the other.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 10, 30, 60 in polypropylene tubes pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg (as hydrochloride) dispersible tablet strip packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesphagitis. The intravenous injection is indicated where oral treatment is inappropriate
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, dispersible
- Oral
- A white, capsule shaped film-coated tablet with a breakline.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 10 tablets pack
- 60 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg (as hydrochloride) dispersible tablet strip packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesphagitis. The intravenous injection is indicated where oral treatment is inappropriate
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, dispersible
- Oral
- A white, capsule shaped film-coated tablet with a breakline.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 10 tablets pack
- 60 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg/10mL (as hydrochloride) oral liquid bottleWhat this medicine is used for
(ARTG)
Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage: maintenance treatment to reduce the risk of relapse in duodenal ulcer: maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer: treatment of gastrinoma (Zollinger-Ellison syndrome): short-term treatment of severe reflux oesophagitis: treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate. NEW INDICATIONS AS AT 2 NOVEMBER 1993: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate. INDICATIONS AS AT 31 OCTOBER 1995: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Oral Liquid
- Oral
- Clear pale yellow liquid in the above container.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 300mL pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 50mg/2mL (as hydrochloride) injection ampouleWhat this medicine is used for
(ARTG)
INDICATIONS AS AT 2 NOVEMBER 1993: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.INDICATIONS AS AT 11 FEBRUARY 2005: 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Intravenous
- Clear colourless to pale yellow liquid, practically free from visible particles.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 5x2mL pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 300 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 300" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 30 tablets pack
- 4 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 150 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 150" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 6 tablets pack
- 60 tablets pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 90 tablets (E) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg (as hydrochloride) effervescent tablet tubeWhat this medicine is used for
(ARTG)
Short term treatment of proven duodenal and gastric ulcer. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. Treatment of gastrinoma (Zollinger-Ellison syndrome). Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. Treatment of scleroderma oesophagitis. NEW INDICATIONS AS AT 2 NOVEMBER 1993: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short- term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and siomple drug therapies such as antacids. 6. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate. INDICATIONS AS AT 31 OCTOBER 1995: Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS LHK" on one side and flat on the other.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 10, 30, 60 in polypropylene tubes pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC ranitidine 150mg (as hydrochloride) effervescent tablet strip packWhat this medicine is used for
(ARTG)
Short term treatment of proven duodenal and gastric ulcer. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. Treatment of gastrinoma (Zollinger-Ellison syndrome). Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. Treatment of scleroderma oesophagitis. INDICATIONS AS AT 2 NOVEMBER 1993: 1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate. INDICATIONS AS AT 31 OCTOBER 1995: 1. Short-term treatment of provenduodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ucler. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, effervescent
- Oral
- White to pale yellow, round, bevelled tablets marked "GS LHK" on one side and flat on the other.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Shelf lifetime is 18 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 4 in foil strips sample pack pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC 75 ranitidine 75mg (as hydrochloride) tabletWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- A pink, five-sided biconvex tablet, engraved with 'Z' on one face and '75' on the other.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
The packs below are available from a pharmacy without prescription. It is Schedule 3 : Pharmacist Only Medicine.
- 12 tablets pack
- 56 tablets pack
- 6 tablets pack
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 120 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC 75 ranitidine 75mg (as hydrochloride) tabletWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- A pink, five-sided biconvex tablet, engraved with 'Z' on one face and '75' on the other.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
The packs below are available from a pharmacy without prescription. It is Schedule 3 : Pharmacist Only Medicine.
- 12 tablets pack
- 56 tablets pack
- 6 tablets pack
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 120 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC 75 ranitidine 75mg (as hydrochloride) tabletWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- A pink, five-sided biconvex tablet, engraved with 'Z' on one face and '75' on the other.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
The packs below are available from a pharmacy without prescription. It is Schedule 3 : Pharmacist Only Medicine.
- 12 tablets pack
- 56 tablets pack
- 6 tablets pack
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 120 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: Suspended from ARTG - ZANTAC 75 ranitidine 75mg (as hydrochloride) tabletWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. Treatment of gastrinoma (Zollinger-Ellison syndrome). 5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. 6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis. 7. Treatment of scleroderma oesophagitis. The intravenous injection is indicated where oral treatment is inappropriate
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- A pink, five-sided biconvex tablet, engraved with 'Z' on one face and '75' on the other.
Storage conditions
(ARTG)
- Store below 30 degrees Celsius
- Store in a Dry Place
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
The packs below are available from a pharmacy without prescription. It is Schedule 3 : Pharmacist Only Medicine.
- 12 tablets pack
- 56 tablets pack
- 6 tablets pack
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 120 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 300 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 300" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 30 tablets pack
- 4 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 300 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 300" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 30 tablets pack
- 4 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 150 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 150" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 6 tablets pack
- 60 tablets pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 90 tablets (E) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 150 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 150" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 6 tablets pack
- 60 tablets pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 90 tablets (E) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: ZANTAC ranitidine 150 mg (as hydrochloride) tablet blister packWhat this medicine is used for
(ARTG)
1. Short-term treatment of proven duodenal ulcer and gastric ulcer for prophylaxis against recurrent haemorrhage.,2. Maintenance treatment to reduce the risk of relapse in duodenal ulcer.,3. Maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer.,4. Treatment of gastrinoma (Zollinger-Ellison syndrome).,5. Short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids.,6. Maintenance treatment to reduce the risk of relapse of reflux oesophagitis.,7. Treatment of scleroderma oesophagitis.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet, film coated
- Oral
- White, film-coated biconvex tablets, engraved on one side with "RAN 150" and plain on the other
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Heat
- Store in a Dry Place
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 2 tablets (starter pack) pack
- 6 tablets pack
- 60 tablets pack
We are unable to tell you if you need a prescription for these medicines. You can ask your pharmacist. This medicine is Not Scheduled.
- 90 tablets (E) pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient ranitidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Heartburn treatments - myDr.com.au
Treatment for heartburn will depend on how often your heartburn occurs and how much it impacts on your life. Treatments include antacids, medicines or surgery, as well as self-help measures.
Read more on MyDoctor website
Heartburn - myDr.com.au
Heartburn is a common form of indigestion caused by gastro-oesophageal reflux - reflux of stomach contents into the oesophagus (gullet).
Read more on MyDoctor website
Infant reflux - Better Health Channel
Reflux is common in babies and causes no pain or problems with weight gain in most babies.
Read more on Better Health Channel website
Hiatus hernia - myDr.com.au
Most hiatus hernias don't cause any symptoms. When symptoms do occur, the most common are heartburn and regurgitation of stomach acid into the mouth.
Read more on MyDoctor website
Top results